{"DataElement":{"publicId":"6687039","version":"1","preferredName":"Neoadjuvant Therapy Administered Type","preferredDefinition":"Text term that represents the kind of neoadjuvant therapy being administered.","longName":"NEOADJ_THRPY_ADMIN_TP","context":"MCL","contextVersion":"1","DataElementConcept":{"publicId":"2188393","version":"1","preferredName":"Neoadjuvant Therapy Administered","preferredDefinition":"information related to neoadjuvant therapy, treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents, being administered.","longName":"NEOADJ_TX_ADM","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2718486","version":"1","preferredName":"Neoadjuvant Therapy","preferredDefinition":"Treatment designed to be used as a first step toward shrinking the cancer and in evaluating response to drugs and other agents. Induction therapy is followed by additional therapy to eliminate whatever cancer remains.","longName":"C15665","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neoadjuvant Therapy","conceptCode":"C15665","definition":"Therapy administered prior to the primary treatment for the purpose of making the primary treatment more effective.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"42D7D4EB-6EB9-0FF3-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-03","modifiedBy":"ONEDATA","dateModified":"2008-01-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233610","version":"1","preferredName":"Administered","preferredDefinition":"Given.","longName":"C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F95D94B9-D864-2792-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-06-13","modifiedBy":"ONEDATA","dateModified":"2005-06-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E40DA276-BE0A-601E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-28","endDate":null,"createdBy":"SHIDED","dateCreated":"2004-09-14","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6118795","version":"1","preferredName":"Adjuvant Therapy Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"ADJUVANT_TX_TP","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"75","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Radiation and pharmaceutical treatment","valueDescription":"Radiation Therapy And Pharmacotherapy","ValueMeaning":{"publicId":"6118796","version":"1","preferredName":"Radiation Therapy And Pharmacotherapy","longName":"6118796","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.: An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.: Treatment of disease through the use of drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"And","conceptCode":"C37912","definition":"An article which expresses the relation of connection or addition. It is used to conjoin a word with a word, a clause with a clause, or a sentence with a sentence.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Pharmacotherapy","conceptCode":"C15986","definition":"Treatment of disease through the use of drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FE793C-7AC2-087B-E053-F662850A8134","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"ONEDATA","dateModified":"2018-03-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66FE793C-7ADB-087B-E053-F662850A8134","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"ONEDATA","dateModified":"2018-03-09","deletedIndicator":"No"},{"value":"Radiation treatment","valueDescription":"Radiation Therapy","ValueMeaning":{"publicId":"2567129","version":"1","preferredName":"Radiation Therapy","longName":"2567129","preferredDefinition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Radiation Therapy","conceptCode":"C15313","definition":"Treatment of a disease by means of exposure of the target or the whole body to radiation. Radiation therapy is often used as part of curative therapy and occasionally as a component of palliative treatment for cancer. Other uses include total body irradiation prior to transplantation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D346-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-10-21","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-10-21","modifiedBy":"KUMMEROA","dateModified":"2023-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66FE793C-7AEF-087B-E053-F662850A8134","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"ONEDATA","dateModified":"2018-03-09","deletedIndicator":"No"},{"value":"Pharmaceutical treatment","valueDescription":"Pharmacotherapy","ValueMeaning":{"publicId":"6118797","version":"1","preferredName":"Pharmacotherapy","longName":"6118797","preferredDefinition":"Treatment of disease through the use of drugs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pharmacotherapy","conceptCode":"C15986","definition":"Treatment of disease through the use of drugs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FE793C-7AF9-087B-E053-F662850A8134","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"66FE793C-7B12-087B-E053-F662850A8134","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"ONEDATA","dateModified":"2018-03-09","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572578","version":"1","preferredName":"Not Reported","longName":"2572578","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E88F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-12-30","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-12-30","modifiedBy":"DWARZEL","dateModified":"2018-03-26","changeDescription":"03/09/2011 - tc - Updated with concept code.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B7C8FC-426A-7179-E053-F662850A6496","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"5682944","version":"1","preferredName":"Unknown","longName":"5682944","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9AE5-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"GDEEN","dateModified":"2023-12-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B802FD-07FD-7171-E053-F662850A63FD","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Data not available","valueDescription":"No Information Available","ValueMeaning":{"publicId":"2578438","version":"1","preferredName":"No Information Available","longName":"2578438","preferredDefinition":"Information regarding the subject is unknown or inaccessible at this time.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No Information Available","conceptCode":"C53269","definition":"Information regarding the subject is unknown or inaccessible at this time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FF73-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-03","endDate":null,"createdBy":"REEVESD","dateCreated":"2006-04-03","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B802FD-0811-7171-E053-F662850A63FD","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Trastuzumab","valueDescription":"Trastuzumab","ValueMeaning":{"publicId":"2576422","version":"1","preferredName":"Trastuzumab","longName":"2576422","preferredDefinition":"A humanized recombinant monoclonal antibody directed against the HER2- receptor protein.  Trastuzumab binds to the extracellular domain of the growth factor protein HER2, thereby inhibiting proliferation of HER2 overexpressing tumor cells.  Binding with HER2 protein also initiates an antibody-dependent cell cytotoxicity.(NCI)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Trastuzumab","conceptCode":"C1647","definition":"A recombinant humanized monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2). After binding to HER2 on the tumor cell surface, trastuzumab induces an antibody-dependent cell-mediated cytotoxicity against tumor cells that overexpress HER2. HER2 is overexpressed by many adenocarcinomas, particularly breast adenocarcinomas. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F793-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-10-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2005-10-04","modifiedBy":"REEVESD","dateModified":"2005-10-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B802FD-0825-7171-E053-F662850A63FD","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Endocrine therapy","valueDescription":"Endocrine Therapy","ValueMeaning":{"publicId":"4340414","version":"1","preferredName":"Endocrine Therapy","longName":"4340414","preferredDefinition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level. The treatment may include administration of hormones or hormone analogs to the patient, or decreasing the level of hormones in the body by using hormone antagonists, or hormone ablation therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hormone Therapy","conceptCode":"C15445","definition":"Various treatment modalities that produce the desired therapeutic effect by means of change of hormone/hormones level.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FAA223A1-46B7-E4F0-E040-BB89AD436356","latestVersionIndicator":"Yes","beginDate":"2014-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-05-30","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B802FD-0839-7171-E053-F662850A63FD","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"},{"value":"Chemotherapy","valueDescription":"Chemotherapy","ValueMeaning":{"publicId":"5102333","version":"1","preferredName":"Chemotherapy","longName":"5102333","preferredDefinition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chemotherapy","conceptCode":"C15632","definition":"The use of synthetic or naturally-occurring chemicals for the treatment of diseases.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"29400305-0232-73D5-E050-BB89AD437D83","latestVersionIndicator":"Yes","beginDate":"2016-01-13","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-01-13","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"85B802FD-0843-7171-E053-F662850A63FD","beginDate":"2019-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-04","modifiedBy":"ONEDATA","dateModified":"2019-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"66FE793C-7AA9-087B-E053-F662850A8134","latestVersionIndicator":"Yes","beginDate":"2018-03-09","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-03-09","modifiedBy":"KNABLEJ","dateModified":"2019-04-04","changeDescription":"Created for Follow-up and metastasis CDE request 3.5.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5506112","version":"1","longName":"Breast","context":"MCL","ClassificationSchemeItems":[{"publicId":"6643182","version":"1","longName":"Planned Order of Treatment","context":"MCL"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Neoadjuvant therapy","type":"Preferred Question Text","description":"Neoadjuvant therapy","url":null,"context":"MCL"}],"origin":"MCL:Molecular and Cellular Characterization of Screened Lesions","workflowStatus":"RELEASED","registrationStatus":"Application","id":"85CF983E-7D91-7454-E053-F662850AADC6","latestVersionIndicator":"Yes","beginDate":"2019-04-05","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-04-05","modifiedBy":"KNABLEJ","dateModified":"2022-03-11","changeDescription":"3/11/22 jk UCSF ISPY-2 AI, released as part of quarterly content review and prior reviews with SMEs.  4/5/19 jk created for Breast planned treatment module.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}